Genetic basis for aggressive tumours discovered

A checkpoint mutation in mice might provide clues to the progression towards aggressive, treatment-resistant cancers, according to a study published in 18 January Nature. Researchers from the Memorial Sloan-Kettering Cancer Center in New York genetically engineered a mutation in the MAD2 gene that eliminates a checkpoint in mitotic division essential for ensuring the equal distribution of chromosomes to the two daughter cells. The mutation caused the tumour cells to become very genetically unsta


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A checkpoint mutation in mice might provide clues to the progression towards aggressive, treatment-resistant cancers, according to a study published in 18 January Nature. Researchers from the Memorial Sloan-Kettering Cancer Center in New York genetically engineered a mutation in the MAD2 gene that eliminates a checkpoint in mitotic division essential for ensuring the equal distribution of chromosomes to the two daughter cells. The mutation caused the tumour cells to become very genetically unstable and resistant to taxanes. "Although the loss of one copy of MAD2 caused only subtle decreases in the amount of MAD2 protein levels, it had a great impact on the cell's genetic behaviour," said Loren Michel, one of the authors. "Our results suggest that developing a similar test to detect the changes in this genetic pathway in human cancer could be used to predict disease progression."

Michel et al also found that the same mutation could initiate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio